Stay updated with breaking news from Nsx Buzz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The clinical research collaboration builds upon its existing strategy of focusing on establishing a better understanding of the basic mechanisms by...
Visitors to the Slim Winkel e-commerce site will be treated to informative blogs and educational tips that will allow them to easily integrate the...
PharmaDrug inks supply deal for the production and sale of THC oil in Germany The company said it will begin selling the THC product in Germany by September, one of several movers it is making to significantly increase its presence and volumes in the German medical cannabis market Pharmadrug said its focus will continue to be on market share growth with a keen eye on revenue growth and profits PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) said it has entered into a supply agreement with a Eurozone cannabis extractor to produce medical-grade THC oil for sale under PharmaDrug's own br...
PharmaDrug agrees to supply agreement with European Cannabis Extractor for medical grade oil PharmaDrug Inc. (CSE: BUZZ- OTC: LMLLF) CEO Daniel Cohen joined Steve Darling from Proactive to share news the company has entered into a supply agreement with a European cannabis extractor for medical grade THC oil. Cohen says that product will be sold under PharmaDrug’s own brand. The Company expects to receive product and begin selling in Germany by September of this year. Quick facts: Pharmadrug Inc
PharmaDrug promotes Dr Paul Van Slyke to Chief Scientific Officer for whole group Van Slyke previously served as the CSO on a consultancy basis of biotech and subsidiary Sairiyo Therapeutics, which PharmaDrug recently acquired Given the advancements in Cepharanthine activities and the quickly evolving DMT strategy, PharmaDrug said it felt Van Slyke's attention was needed "on an exclusive and full-time basis" PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) has named entrepreneur-scientist and experienced pharma executive Dr Paul Van Slyke as the new Chief Scientific Officer (CSO) for the...